API Holdings, the parent company of online pharmacy PharmEasy, announced last week that it would pick up a 66.1 per cent stake in diagnostics firm Thyrocare for Rs 4,546 crore. It is the first unicorn to acquire a listed company.
- Indian Oil Announced Q4 Earnings; Net Profit Plunges 49%
- RVNL Shares Gain as JV Secures Project Worth Rs 438 Crore
- Granules Shares Gain 2% on USFDA Approval
- Patanjali Foods Shares Slump 4% on Receiving Show Cause Notice
- KEC International Shares Rally 6% on Securing Orders Worth Rs 1,036 crore
One of the most extensive consolidations in the domestic health care space, the deal was struck in record time at the Mumbai residence of A Velumani, founder of Thyrocare. The deal is also a milestone for five friends from the Mumbai suburb of Ghatkopar, who called themselves the Ghatkopar Gujju gang and set up PharmEasy in 2015.